EDITORIAL
Published on 28 Mar 2023
Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
doi 10.3389/fonc.2023.1180650
- 764 views
- 1 citation
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Inhibitors of CDK family: New Perspective and Rationale for Drug Combination in Preclinical Model of Solid Tumors
Inhibitors of CDK family: New Perspective and Rationale for Drug Combination in Preclinical Model of Solid Tumors
9,014
Total downloads
29k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 03 Feb 2023
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy
doi 10.3389/fphar.2023.970457
- 3,362 views
- 5 citations
REVIEW
Published on 19 Jan 2023
Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
doi 10.3389/fonc.2023.1095219
- 2,456 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Aug 2022
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
doi 10.3389/fphar.2022.958443
- 3,001 views
- 22 citations
REVIEW
Published on 08 Aug 2022
Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application
doi 10.3389/fonc.2022.957844
- 1,950 views
- 9 citations
ORIGINAL RESEARCH
Published on 22 Jul 2022
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
doi 10.3389/fonc.2022.942341
- 2,902 views
- 12 citations
ORIGINAL RESEARCH
Published on 13 Jul 2022
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment
doi 10.3389/fonc.2022.903536
- 3,270 views
- 3 citations
ORIGINAL RESEARCH
Published on 25 May 2022
Tizoxanide Promotes Apoptosis in Glioblastoma by Inhibiting CDK1 Activity
doi 10.3389/fphar.2022.895573
- 2,206 views
- 10 citations
ORIGINAL RESEARCH
Published on 08 Apr 2022
CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
doi 10.3389/fonc.2022.819003
- 1,548 views
- 2 citations
ORIGINAL RESEARCH
Published on 22 Feb 2022
Adapalene Inhibits Prostate Cancer Cell Proliferation In Vitro and In Vivo by Inducing DNA Damage, S-phase Cell Cycle Arrest, and Apoptosis
doi 10.3389/fphar.2022.801624
- 2,994 views
- 10 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 29kTopic views
- 19kArticle views
- 9,014Article downloads